202 filings
10-K
2023 FY
ALBT
Avalon GloboCare Corp
Annual report
15 Apr 24
5:08pm
NT 10-K
ALBT
Avalon GloboCare Corp
1 Apr 24
Notice of late annual filing
4:30pm
8-K
ALBT
Avalon GloboCare Corp
27 Mar 24
Entry into a Material Definitive Agreement
4:10pm
8-K
ALBT
Avalon GloboCare Corp
22 Nov 23
Entry into a Material Definitive Agreement
4:49pm
10-Q
2023 Q3
ALBT
Avalon GloboCare Corp
Quarterly report
14 Nov 23
4:30pm
8-K
7r7vngxz 9q
9 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
D
ouqe38ims2ivzobfnm
20 Oct 23
$700.00 k in Convertible Debt, sold $700.00 k, 2 investors
4:18pm
8-K
0hqviq15 u13ehx
13 Oct 23
Entry into a Material Definitive Agreement
4:30pm
8-K
pt2 bgz9dmz9t4my
13 Oct 23
Departure of Directors or Certain Officers
9:15am
ARS
8fn8x hupbxxw
8 Sep 23
Annual report to shareholders
5:21pm
8-K
gjj5ez
5 Sep 23
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules
8:56am
PRE 14A
2ibqjme
29 Aug 23
Preliminary proxy
4:55pm
8-K
n6b3n07bcqlf1zpbxdk0
21 Aug 23
Avalon’s Laboratory Services MSO Announces Expansion into Arizona
9:11am
8-K
dtt74nocb7dyj x0
24 Jul 23
Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth
9:05am
8-K
xazks8nimp79x3st4
19 Jul 23
Regulation FD Disclosure
9:21am
8-K
8d2sckkbc6ke k0pc
7 Jul 23
Entry into a Material Definitive Agreement
5:49pm
424B3
zmadw5uc
29 Jun 23
Prospectus supplement
4:31pm
EFFECT
443e wccx
29 Jun 23
Notice of effectiveness
12:15am